Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | — | 1 |
Drug common name | Guadecitabine |
INN | guadecitabine |
Description | Guadecitabine is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Small molecule |
Drug class | nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Nc1ncn([C@H]2C[C@H](OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(=O)[nH]c(N)nc54)C[C@@H]3O)[C@@H](CO)O2)c(=O)n1 |
PDB | — |
CAS-ID | 929901-49-5 |
RxCUI | — |
ChEMBL ID | CHEMBL3544916 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 2KT4YN1DP7 (ChemIDplus, GSRS) |